1. Home
  2. VNDA vs ARQ Comparison

VNDA vs ARQ Comparison

Compare VNDA & ARQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • ARQ
  • Stock Information
  • Founded
  • VNDA 2002
  • ARQ 1996
  • Country
  • VNDA United States
  • ARQ United States
  • Employees
  • VNDA N/A
  • ARQ N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • ARQ
  • Sector
  • VNDA Health Care
  • ARQ
  • Exchange
  • VNDA Nasdaq
  • ARQ NYSE
  • Market Cap
  • VNDA 270.2M
  • ARQ 249.0M
  • IPO Year
  • VNDA 2006
  • ARQ N/A
  • Fundamental
  • Price
  • VNDA $5.09
  • ARQ $6.99
  • Analyst Decision
  • VNDA Strong Buy
  • ARQ
  • Analyst Count
  • VNDA 2
  • ARQ 0
  • Target Price
  • VNDA $15.50
  • ARQ N/A
  • AVG Volume (30 Days)
  • VNDA 775.4K
  • ARQ 163.7K
  • Earning Date
  • VNDA 11-06-2024
  • ARQ 11-07-2024
  • Dividend Yield
  • VNDA N/A
  • ARQ N/A
  • EPS Growth
  • VNDA N/A
  • ARQ N/A
  • EPS
  • VNDA N/A
  • ARQ N/A
  • Revenue
  • VNDA $190,858,000.00
  • ARQ $110,023,000.00
  • Revenue This Year
  • VNDA $6.70
  • ARQ $6.31
  • Revenue Next Year
  • VNDA $51.03
  • ARQ $31.95
  • P/E Ratio
  • VNDA N/A
  • ARQ N/A
  • Revenue Growth
  • VNDA N/A
  • ARQ 16.44
  • 52 Week Low
  • VNDA $3.30
  • ARQ $1.94
  • 52 Week High
  • VNDA $6.75
  • ARQ $8.26
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 59.66
  • ARQ 71.76
  • Support Level
  • VNDA $4.56
  • ARQ $5.87
  • Resistance Level
  • VNDA $4.89
  • ARQ $6.15
  • Average True Range (ATR)
  • VNDA 0.18
  • ARQ 0.22
  • MACD
  • VNDA 0.04
  • ARQ 0.08
  • Stochastic Oscillator
  • VNDA 66.67
  • ARQ 94.17

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.

About ARQ ARQ INC

Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granular Activated Carbon, and Colloidal Carbon Product among others.

Share on Social Networks: